Etoricoxib>95.0%(HPLC)(T)1g

2-(4,4-Difluoropiperidin-1-yl)-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine, 98%, 1mg

(3S)-3-Hydroxyoctanoic acid, 95%, 1g

5-Bromo-quinolin-8-ylamine, 95.0%, 5g

5-Chloro-1-piperidin-4-yl-1,3-dihydro-2H-benzimidazol-2-one, 97.0%, 25g

2-(4-Bromophenyl)propan-2-amine hydrochloride, 95.0%, 1g

Fargesin, 98.17%, 50mg

2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-oxo-, 1,1-dimethylethylester, (1S,4R)-, 97%, 5g

2-(2-Propoxyphenoxy)acetic acid, 95%, 5g

3-Bromo-2-chloro-6-methyl-5-nitropyridine, 95.0%, 5g

1-Ethyl-3-methyl-imidazolium thiocyanate, min. 98%, 100 g, glass packaging

ethyl (2Z)-2-chloro-2-[2-(3,4-dimethylphenyl)hydrazin-1-ylidene]acetate, 95.0%, 1g

N-(p-Toluenesulfonyl)-L-phenylalanyl Chloride [Optical Resolving Reagent for Alcohols]>97.0%(T)5g